Accolade Inc
NASDAQ:ACCD
Accolade Inc
Non-Reccuring Items
Accolade Inc
Non-Reccuring Items Peer Comparison
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Non-Reccuring Items
-$300.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Non-Reccuring Items
-$34m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Non-Reccuring Items
-$12m
|
CAGR 3-Years
9%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Non-Reccuring Items
-$994m
|
CAGR 3-Years
12%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Non-Reccuring Items
-$2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-68%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Non-Reccuring Items
-$395.9m
|
CAGR 3-Years
-97%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-34%
|
See Also
What is Accolade Inc's Non-Reccuring Items?
Non-Reccuring Items
-300.9m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Non-Reccuring Items amounts to -300.9m USD.
What is Accolade Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 1Y
-2 180%
Over the last year, the Non-Reccuring Items growth was -2 180%.